Abstract
Objective: Hepatic encephalopathy (HE) is a neuropsychiatric syndrome resulting from liver failure. In the present study, we aimed to standardize an animal model of HE induced by thioacetamide (TAA) in C57BL/6 mice evaluating behavioral symptoms in association with liver damage and alterations in neurotransmitter release. Method: HE was induced by an intraperitoneal single dose of TAA (200 mg/kg, 600 mg/kg or 1,200 mg/kg). Behavioral symptoms were evaluated using the SHIRPA battery. Liver damage was confirmed by histopathological analysis. The glutamate release was measured using fluorimetric assay. Results: The neuropsychiatric state, motor behavior and reflex and sensory functions were significantly altered in the group receiving 600 mg/kg of TAA. Biochemical analysis revealed an increase in the glutamate release in the cerebral cortex of HE mice. Conclusion: HE induced by 600mg/kg TAA injection in C57BL/6 mice seems to be a suitable model to investigate the pathogenesis and clinical disorders of HE.
Translated title of the contribution | A thioacetamide-induced hepatic encephalopathy model in C57BL/6 mice: A behavioral and neurochemical study |
---|---|
Original language | Portuguese |
Pages (from-to) | 597-602 |
Number of pages | 6 |
Journal | Arquivos de neuro-psiquiatria |
Volume | 68 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2010 |
Externally published | Yes |
Keywords
- Behavioral changes
- Glutamate
- Hepatic encephalopathy
- SHIRPA
- Thioacetamide
ASJC Scopus subject areas
- Clinical Neurology
- Biological Psychiatry